Skip to content
VuFind
    • English
    • Deutsch
    • Español
    • Français
    • Italiano
    • 日本語
    • Nederlands
    • Português
    • Português (Brasil)
    • 中文(简体)
    • 中文(繁體)
    • Türkçe
    • עברית
    • Gaeilge
    • Cymraeg
    • Ελληνικά
    • Català
    • Euskara
    • Русский
    • Čeština
    • Suomi
    • Svenska
    • polski
    • Dansk
    • slovenščina
    • اللغة العربية
    • বাংলা
    • Galego
    • Tiếng Việt
    • Hrvatski
    • हिंदी
    • Հայերէն
    • Українська
    • Sámegiella
    • Монгол
Advanced
  • Corrigendum: CD317-Positive Im...
  • Cite this
  • Text this
  • Email this
  • Print
  • Export Record
    • Export to RefWorks
    • Export to EndNoteWeb
    • Export to EndNote
  • Permanent link
Corrigendum: CD317-Positive Immune Stromal Cells in Human “Mesenchymal Stem Cell” Populations

Corrigendum: CD317-Positive Immune Stromal Cells in Human “Mesenchymal Stem Cell” Populations

Bibliographic Details
Main Authors: Alasdair G. Kay, James M. Fox, James P. Hewitson, Andrew P. Stone, Sophie Robertson, Sally James, Xiao-nong Wang, Elizabeth Kapasa, Xuebin B. Yang, Paul G. Genever
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-12-01
Series:Frontiers in Immunology
Subjects:
mesenchymal stromal cells
MSC subtypes
heterogeneity
immunomodulation
CD317
BST2
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2022.1111042/full
  • Holdings
  • Description
  • Similar Items
  • Staff View

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2022.1111042/full

Similar Items

  • CD317-Positive Immune Stromal Cells in Human “Mesenchymal Stem Cell” Populations
    by: Alasdair G. Kay, et al.
    Published: (2022-06-01)
  • Enhancing Immunomodulatory Function of Mesenchymal Stromal Cells by Hydrogel Encapsulation
    by: Hui-Yun Cheng, et al.
    Published: (2024-01-01)
  • Enriched osteogenic potential of CD317-negative mesenchymal stromal cell populations in vitro and in vivo
    by: Alasdair G. Kay, et al.
    Published: (2020-10-01)
  • The Current Status of Mesenchymal Stromal Cells: Controversies, Unresolved Issues and Some Promising Solutions to Improve Their Therapeutic Efficacy
    by: David García-Bernal, et al.
    Published: (2021-03-01)
  • Impacts of priming on distinct immunosuppressive mechanisms of mesenchymal stromal cells under translationally relevant conditions
    by: Nick Herger, et al.
    Published: (2024-03-01)

Search Options

  • Search History
  • Advanced Search

Find More

  • Browse the Catalog
  • Browse Alphabetically
  • Explore Channels
  • Course Reserves
  • New Items

Need Help?

  • Search Tips
  • Ask a Librarian
  • FAQs